ENTITY
Mylan NV

Mylan NV (MYL US)

55
Analysis
Health Care • United States
Mylan NV is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.
more
bullish•Allergan Plc
•09 Sep 2016 11:46

Allergan's Wide Moat Supports Industry-Leading Growth and Profit

Innovative products, strong IP, and an unmatched aesthetics franchise drive Allergan's growth outlook. We anticipate high-single-digit growth for...

Share
•09 Aug 2016 18:52

A 'heads Up' on Changing World Heights

A comprehensive world survey of population heights over the last century has thrown up some surprising results. Americans have had the smallest...

Logo
304 Views
Share
•07 Jul 2016 10:21

No Pain, Potential for Lots of Gain for Pfizer, Lilly, and Regeneron

The history of pain drugs that target nerve growth factor has been a roller-coaster ride for drug developers and investors. In 2010, expectations...

Share
•15 Apr 2016 11:33

Healthcare Observer: Orthopedic Innovation Beyond Large Joint Market Fuels Long-Term Growth

Over the next decade, we expect orthopedic innovation in extremities, robotics, and 3-D printing to be key drivers of growth as fee-for-value...

Share
x